TOLNAFTATE 1% and GRAFT VERSUS HOST DISEASE

Overview

GRAFT VERSUS HOST DISEASE is the #18 most commonly reported adverse reaction for TOLNAFTATE 1%, manufactured by Meijer Distribution Inc. There are 11 FDA adverse event reports linking TOLNAFTATE 1% to GRAFT VERSUS HOST DISEASE. This represents approximately 1.5% of all 724 adverse event reports for this drug.

Patients taking TOLNAFTATE 1% who experience graft versus host disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

GRAFT VERSUS HOST DISEASE is a less commonly reported adverse event for TOLNAFTATE 1%, but still significant enough to appear in the safety profile.

Other Side Effects of TOLNAFTATE 1%

In addition to graft versus host disease, the following adverse reactions have been reported for TOLNAFTATE 1%:

• DIARRHOEA — 23 reports
• ARTHRALGIA — 17 reports
• DYSPNOEA — 16 reports
• DRUG INEFFECTIVE — 14 reports
• PNEUMONIA — 14 reports
• BLOOD POTASSIUM INCREASED — 13 reports
• GASTROINTESTINAL DISORDER — 13 reports
• HEADACHE — 13 reports
• RASH ERYTHEMATOUS — 13 reports
• BRONCHOPULMONARY ASPERGILLOSIS — 12 reports

Other Drugs Associated with GRAFT VERSUS HOST DISEASE

The following drugs have also been linked to graft versus host disease in FDA adverse event reports:

Does TOLNAFTATE 1% cause GRAFT VERSUS HOST DISEASE?

GRAFT VERSUS HOST DISEASE has been reported as an adverse event in 11 FDA reports for TOLNAFTATE 1%. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is GRAFT VERSUS HOST DISEASE with TOLNAFTATE 1%?

GRAFT VERSUS HOST DISEASE accounts for approximately 1.5% of all adverse event reports for TOLNAFTATE 1%, making it a notable side effect.

What should I do if I experience GRAFT VERSUS HOST DISEASE while taking TOLNAFTATE 1%?

If you experience graft versus host disease while taking TOLNAFTATE 1%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages